FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely ophthalmology. A method involves the intravenous drop-by-drop introduction of chlorine photosensitiser (PS) 0.4-0.5 mg/kg for 10 minutes. Immediately after the PS introduction, filtration points are exposed to transpupillary laser light on the basis of fluorescent angiography values. That is ensured by laser light at wave length matched to maximum PS adsorption of optical emission. Power density of the exposure is 20-25 J/cm2.
EFFECT: method provides the absence of damaging action on the pigment epithelium and the neurosensory retina, the absence of extravasal fluorescence as shown by the FAG values, improved visual acuity ensured by gradual laser exposure on the retina within the filtration points.
2 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD CHOROIDAL NEOVASCULAR MEMBRANES PHOTODYNAMIC THERAPY | 2007 |
|
RU2333022C1 |
PHOTODYNAMIC METHOD FOR TREATING CHOROID NEOVASCULAR MEMBRANES | 2004 |
|
RU2274436C1 |
METHOD OF INCREASING EFFECIENCY OF PHOTODYNAMIC THERAPY OF CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2375023C1 |
METHOD OF LASER TREATMENT OF CHRONIC RECURRENT CENTRAL SEROUS CHORIORETINOPATHY | 2018 |
|
RU2682496C1 |
METHOD OF DIFFERENTIATED APPROACH TO SURGICAL TREATMENT OF CHRONIC FORM OF CENTRAL SEROUS CHORIORETINOPATHY | 2024 |
|
RU2823160C1 |
METHOD FOR COMBINED TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY WITH PRESENCE OF TWO OR MORE FILTRATION POINTS | 2016 |
|
RU2613563C1 |
METHOD FOR DETERMINING THE TACTICS OF LASER TREATMENT OF ACUTE AND CHRONIC CENTRAL SEROUS CHORIORETINOPATHY | 2018 |
|
RU2674382C1 |
METHOD OF SUBRETINAL NEOVASCULAR MEMBRANE TREATMENT | 2008 |
|
RU2376957C1 |
LASER TREATMENT METHOD IN CENTRAL SEROUS CHORIORETINOPATHY WITH NEUROEPITHELIAL DETACHMENT IN THE MACULAR AREA | 2020 |
|
RU2724278C1 |
METHOD FOR PHOTODYNAMIC THERAPY OF PROLIFERATIVE DIABETIC RETINOPATHY | 2010 |
|
RU2447870C1 |
Authors
Dates
2012-04-20—Published
2010-08-25—Filed